These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 27053534)

  • 1. Welcoming a new age for gene therapy in hematology.
    Weiss MJ; Mullighan CG
    Blood; 2016 May; 127(21):2523-4. PubMed ID: 27053534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A genome editing primer for the hematologist.
    Hoban MD; Bauer DE
    Blood; 2016 May; 127(21):2525-35. PubMed ID: 27053532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A conversation with Oliver Smithies.
    Smithies O; Coffman T
    Annu Rev Physiol; 2015; 77():1-11. PubMed ID: 25668016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene editing and its application for hematological diseases.
    Osborn MJ; Belanto JJ; Tolar J; Voytas DF
    Int J Hematol; 2016 Jul; 104(1):18-28. PubMed ID: 27233509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome editing: A breakthrough in life science and medicine.
    Hatada I; Horii T
    Endocr J; 2016; 63(2):105-10. PubMed ID: 26698412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The Nobel Prize in Physiology or Medicine 2007 for the development of 'knockout' technology].
    Dijkstra CD; Walvoort HC
    Ned Tijdschr Geneeskd; 2007 Dec; 151(52):2875-6. PubMed ID: 18257431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of genome editing technologies to the study and treatment of hematological disease.
    Pellagatti A; Dolatshad H; Yip BH; Valletta S; Boultwood J
    Adv Biol Regul; 2016 Jan; 60():122-134. PubMed ID: 26433620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene targeting in embryonic stem cells scores a knockout in Stockholm.
    Mak TW
    Cell; 2007 Dec; 131(6):1027-31. PubMed ID: 18083089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A conversation with Oliver Smithies.
    Smithies O; Neill US
    J Clin Invest; 2015 Nov; 125(11):3997-8. PubMed ID: 26524588
    [No Abstract]   [Full Text] [Related]  

  • 10. Gene Editing of Human Hematopoietic Stem and Progenitor Cells: Promise and Potential Hurdles.
    Yu KR; Natanson H; Dunbar CE
    Hum Gene Ther; 2016 Oct; 27(10):729-740. PubMed ID: 27483988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical applications of genome editing in HIV.
    Wang CX; Cannon PM
    Blood; 2016 May; 127(21):2546-52. PubMed ID: 27053530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR/Cas9 genome engineering in hematopoietic cells.
    Sürün D; von Melchner H; Schnütgen F
    Drug Discov Today Technol; 2018 Aug; 28():33-39. PubMed ID: 30205879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mouse models of hematological diseases using genome editing technology].
    Nagamachi A; Inaba T
    Rinsho Ketsueki; 2022; 63(11):1551-1557. PubMed ID: 36476797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene targeting in mice: functional analysis of the mammalian genome for the twenty-first century.
    Capecchi MR
    Nat Rev Genet; 2005 Jun; 6(6):507-12. PubMed ID: 15931173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR/Cas9 genome editing in human hematopoietic stem cells.
    Bak RO; Dever DP; Porteus MH
    Nat Protoc; 2018 Feb; 13(2):358-376. PubMed ID: 29370156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. At the Heart of Genome Editing and Cardiovascular Diseases.
    Hernandez-Benitez R; Martinez-Martinez ML; Lajara J; Magistretti P; Montserrat N; Izpisua Belmonte JC
    Circ Res; 2018 Jul; 123(2):221-223. PubMed ID: 29976689
    [No Abstract]   [Full Text] [Related]  

  • 17. Generating mouse lines for lineage tracing and knockout studies.
    Kraus P; Sivakamasundari V; Xing X; Lufkin T
    Methods Mol Biol; 2014; 1194():37-62. PubMed ID: 25064097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TALEN- and CRISPR-enhanced DNA homologous recombination for gene editing in zebrafish.
    Zhang Y; Huang H; Zhang B; Lin S
    Methods Cell Biol; 2016; 135():107-20. PubMed ID: 27443922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of CRISPR/Cas9 systems in hematology research.
    Lucas D; O'Leary HA; Ebert BL; Cowan CA; Tremblay CS
    Exp Hematol; 2017 Oct; 54():1-3. PubMed ID: 28668351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR-Cas9 Targeting of PCSK9 in Human Hepatocytes In Vivo-Brief Report.
    Wang X; Raghavan A; Chen T; Qiao L; Zhang Y; Ding Q; Musunuru K
    Arterioscler Thromb Vasc Biol; 2016 May; 36(5):783-6. PubMed ID: 26941020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.